Home » Pfizer, Sandoz Agree to End Caduet Patent Fight
Pfizer, Sandoz Agree to End Caduet Patent Fight
A Delaware federal judge dismissed consolidated patent litigation between Pfizer and Sandoz over Pfizer’s blood pressure and cholesterol drug Caduet, after they agreed to drop the dispute.
Law360
Law360
Upcoming Events
-
07May
-
14May
-
30May